Verano Holdings (VRNO) Non-Current Deffered Revenue (2021 - 2023)
Verano Holdings (VRNO) reported Non-Current Deffered Revenue of $255000.0 for Q1 2023, little changed quarter-over-quarter from $255000.0 in Q4 2022.
Verano Holdings (VRNO) Non-Current Deffered Revenue (2021 - 2023) Analysis & Trends
Verano Holdings (VRNO) has 3 years of Non-Current Deffered Revenue data on file, last reported at $255000.0 in Q1 2023.
- Non-Current Deffered Revenue for Q1 2023 came in at $255000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2023 was $255000.0 (changed N/A YoY), and the FY2022 annual result was $255000.0, down 78.44% from the prior year.
- Non-Current Deffered Revenue was little changed at $255000.0 in Q1 2023 per VRNO's latest filing, from $255000.0 in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $1.2 million in Q4 2021 and troughed at $215000.0 in Q3 2022.
- A 3-year average of $435800.0 and a median of $255000.0 in 2022 frame the typical range for Non-Current Deffered Revenue.
- On a YoY basis, Non-Current Deffered Revenue climbed as much as 78.44% in 2022 and fell as far as 78.44% in 2022.
- A 3-year view of Non-Current Deffered Revenue shows it stood at $1.2 million in 2021, then tumbled by 78.44% to $255000.0 in 2022, then changed by 0.0% to $255000.0 in 2023.
- Business Quant data shows VRNO's Non-Current Deffered Revenue at $255000.0 in Q1 2023, $255000.0 in Q4 2022, and $215000.0 in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Verano Holdings | - | - | 98.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 255,000.00 |
| Dec 31, 2022 | 255,000.00 |
| Sep 30, 2022 | 215,000.00 |
| Jun 30, 2022 | 271,000.00 |
| Dec 31, 2021 | 1.18 Mn |